RxDoctor Payments Data

John Schwerdt, DPM

Podiatrist · New Windsor, NYNPI 1760706436

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,895 of the $13,396 with a category attached, or 88.8%. It is spread thinly across 39 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,396in general payments, 2019–2025

Across 355 payments — averaging $37.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Smith+Nephew$2K
  • Organogenesis Inc.$2K
  • Seapearl East, Inc$815
  • Paragon 28, Inc.$764
  • KCI USA, Inc.$642
  • plus $5K from 33 others

What the payments were for

  • Consulting fees$3152%
  • Travel & lodging$7696%
  • Food & beverage$11,89589%
  • Education$4173%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,396 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$200,279
Medicare patients
398
Services billed
2,434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate108$2,585
Ketoconazole53$1,453
Ciclopirox30$1,366
Mupirocin78$693
Doxycycline Hyclate45$594
Clindamycin Hcl27$257
Cephalexin14$152
Terbinafine Hcl17$149
Meloxicam23$72
Triamcinolone Acetonide13$66

Paid to pharmacies, not to this prescriber.

Other podiatrist in New Windsor

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →